Increased cardiac adenylyl cyclase expression is associated with increased survival after myocardial infarction

Circulation

Volumn 114, Issue 5, 2006, Pages 388-396

  Takahashi, Toshiyuki ^a,c   Tang, Tong ^a,c   Lai, N Chin ^a,c   Roth, David M ^b,c   Rebolledo, Brian ^c   Saito, Miho ^c   Lew, Wilbur Y W ^a,c   Clopton, Paul ^c   Hammond, H Kirk ^a,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b University of California   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

cAMP; Coronary disease; Gene therapy; Receptors, adrenergic, beta; Signal transduction

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENYLATE CYCLASE; PROPRANOLOL; ADENYLYL CYCLASE 6; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION; HEART PERFUSION; HEMODYNAMICS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOPLASMIC RETICULUM; SURVIVAL; ANIMAL; APOPTOSIS; CHEMISTRY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HEART CONTRACTION; HEART VENTRICLE; HEART VENTRICLE REMODELING; METABOLISM; MORTALITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SURVIVAL RATE; TRANSGENIC MOUSE;

ADENYLATE CYCLASE; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; APOPTOSIS; CALCIUM; CYCLIC AMP; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GTP-BINDING PROTEINS; HEART VENTRICLES; HEMODYNAMIC PROCESSES; MALE; MICE; MICE, TRANSGENIC; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; PROPRANOLOL; RECEPTORS, ADRENERGIC, BETA; SURVIVAL RATE; VENTRICULAR REMODELING;

EID: 33746206024     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.632513     Document Type: Article

References (26)

1. Gao MH, Lai NC, Roth DM, Zhou J, Zhu J, Anzai T, Dalton N, Hammond HK. Adenylylcyclase increases responsiveness to catecholamine stimulation in transgenic mice. Circulation. 1999;99:1618-1622.
2. Bayat H, Swaney JS, Ander AN, Dalton N, Kennedy BP, Hammond HK, Roth DM. Progressive heart failure after myocardial infarction in mice. Basic Res Cardiol. 2002;97:206-213.
3. Jones SP, Girod WG, Palazzo AJ, Granger DN, Grisham MB, Jourd'heuil D, Huang PL, Lefer DJ. Myocardial ischemia-reperfusion injury is exacerbated in the absence of endothelial cell nitric oxide synthase. Am J Physiol. 1999;276:H1567-H1573.
4. Fuchs M, Hilfiker A, Kaminski K, Hilfiker-Kleiner D, Guener Z, Klein G, Podewski E, Schieffer B, Rose-John S, Drexler H. Role of interleukin-6 for LV remodeling and survival after experimental myocardial infarction. FASEB J. 2003;17:2118-2120.
5. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. Am Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358-367.
6. Li HL, Suzuki J, Bayna E, Zhang FM, Dalle Molle E, Clark A, Engler RL, Lew WYW. Lipopolysaccharide induces apoptosis in adult rat ventricular myocytes via cardiac AT1 receptors. Am J Physiol. 2002;283:H461-H467.
7. Palojoki E, Saraste A, Eriksson A, Pulkki K, Kallajoki M, Voipio-Pulkki LM, Tikkanen I. Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am J Physiol. 2001;280:H2726-H2731.
8. 1- adrenergic receptors in the cochlea and vestibular labyrinth. J Membrane Biol. 2004;201:25-32.
9. Tang T, Gao MH, Roth DM, Guo T, Hammond HK. Adenylyl cyclase type VI corrects cardiac sarcoplasmic reticulum calcium uptake defects in cardiomyopathy. Am J Physiol. 2004;287:H1096-H1112.
10. Lai NC, Roth DM, Gao MH, Tang T, Dalton N, Lai YY, Spellman M, Clopton P, Hammond HK. Intracoronary adenovirus encoding adenylyl cyclase VI increases left ventricular function in heart failure. Circulation. 2004;110:330-336.
11. Roth DM, Drumm JD, Bhargava V, Swaney JS, Gao MH, Hammond HK. Cardiac-directed expression of adenylyl cyclase and heart rate regulation. Basic Res Cardiol. 2003;98:380-387.
12. Uechi M, Asai K, Osaka M, Smith A, Sato N, Wagner TE, Ishikawa Y, Hayakawa H, Vatner DE, Shannon RP, Homcy CJ, Vatner SF. Depressed heart rate variability and arterial baroreflex in conscious transgenic mice with overexpression of cardiac Gsα. Circ Res. 1998;82:416-423.
13. Norager B, Husic M, Moller JE, Pellikka PA, Appleton CP, Egstrup K. The Doppler myocardial performance index during low-dose dobutamine echocardiography predicts mortality and left ventricular dilation after a first acute myocardial infarction. Am Heart J. 2005;150:522-529.
14. Migrino RQ, Young JB, Ellis SG, White HD, Lundergan CF, Miller DP, Granger CB, Ross AM, Califf RM, Topol EJ; The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic Investigators. End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. Circulation. 1997;96:116-121.
15. 2+-ATPase in failing and nonfailing human myocardium. Cir Res. 1994;75:434-442.
16. Wehrens XH, Lehnart SE, Huang F, Vest JA, Reiken SR, Mohler PJ, Sun J, Guatimosim S, Song LS, Rosemblit N, D'Armiento JM, Napolitano C, Memmi M, Priori SG, Lederer WJ, Marks AR. FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell. 2003;113:829-840.
17. Hoshijima M, Ikeda Y, Iwanaga Y, Minamisawa S, Date MO, Gu Y, Iwatate M, Li M, Wang L, Wilson JM, Wang Y, Ross J Jr., Chien KR. Chronic suppression of heart failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat Med. 2002;8:864-871.
18. Singh K, Xiao L, Remondino A, Sawyer DB, Colucci WS. Adrenergic regulation of cardiac myocyte apoptosis. J Cell Physiol. 2001;189:257-265.
19. Engelhardt S, Hein L, Wiesmann F, Lohse MJ. Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc Natl Acad Sci U S A. 1999;96:7059-7064.
20. Luu M, Stevenson LW, Brunken RC, Drinkwater DC, Schelbert HR, Tillisch JH. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation. 1989;80:1675-1680.
21. Betsuyaku T, Kanno S, Lerner DL, Schuessler RB, Saffitz JE, Yamada KA. Spontaneous and inducible ventricular arrhythmias after myocardial infarction in mice. Cardiovasc Pathol. 2004;13:156-164.
22. Sastry A, Arnold E, Gurji H, Iwasi A, Bui H, Hassankhani A, Patel HH, Feramisco JR, Roth DM, Lai NC, Hammond HK, Narayan SM. Cardiac-directed expression of adenylyl cyclase VI facilitates atrioventricular conduction. J Am Coll Cardiol. In press.
23. Gao MH, Tang T, Guo T, Sun S, Feramisco JR, Hammond HK. Adenylyl cyclase type VI gene transfer reduces phospholamban expression in cardiac myocytes via activating transcription factor 3. J Biol Chem. 2004;279:38797-38802.
24. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2004;110:e82-e292.
25. The MIAMI Trial Research Group. Metoprolol in acute myocardial infarction (MIAMI): a randomized placebo-controlled international trial. Eur Heart J. 1985;6: 199-226.
26. Bristow MR. β-Adrenergic receptor blockade in chronic heart failure Circulation. 2000;101:558-569